Anti-Inflammatory Efficacy of a Functional Shampoo Mixed With 0.063% Artemether for Seborrheic Dermatitis

Area of Science:

• Dermatology
• Pharmacology
• Inflammation Research

Background:

• Seborrheic dermatitis (SD) is a chronic inflammatory skin condition.
• Artemisinin derivatives show therapeutic potential for skin diseases but haven't been studied for SD.

Purpose of the Study:

• To assess the therapeutic and anti-inflammatory efficacy of 0.063% artemether shampoo on seborrheic dermatitis.
• To evaluate artemether's effects using a guinea pig model.

Main Methods:

• Fifty guinea pigs with induced SD were divided into control, ketoconazole (2%), matrix, and artemether (0.063%) groups.
• Treatments were applied twice weekly for two weeks, with erythema and scaling scored.
• Lesional levels of IL-1β, IL-8, IL-17, NF-κB, and histamine H1 were quantified using immunohistochemistry.

Main Results:

• Artemether shampoo significantly reduced SD symptoms compared to control and matrix groups (p < 0.05).
• Its efficacy was comparable to ketoconazole (p > 0.05).
• Artemether notably suppressed IL-1β, IL-8, NF-κB, and histamine H1 levels, with IL-8 suppression being more potent than ketoconazole or matrix treatments (p < 0.05; p < 0.001).

Conclusions:

• 0.063% artemether shampoo demonstrates clinical effectiveness for seborrheic dermatitis, on par with 2% ketoconazole shampoo.
• Artemether shampoo may possess superior anti-inflammatory properties compared to existing treatments.